Accordingly, treatment with non-antigen-specific IgA significantly delayed the growth of OVCAR3 tumours in RAG1-deficient tumour-bearing mice, compared to control IgG or pepsinized IgA (Extended Data Fig. 5a–c). The gene discussed is RAG1; the disease is neoplasm.